Document is current
Any future updates will be listed below
-
Authors
Rhodin, Kristen E.
Beasley, Georgia M.
-
Funding
Funding for this research was provided by:
NIH (1R38AI140297)
- License Information
-
More Information
Article History
Received: 5 July 2023
Accepted: 6 July 2023
First Online: 23 July 2023
Disclosures
: K. Rhodin is supported by NIH 1R38AI140297. G. Beasley has received clinical trial funding paid to Duke University from Delcath, Istari, Replimune, Oncosec, and Checkmate. G. Beasley has done one-time advisory board for Cardinal Health, Regeneron. G. Beasley is supported by NIH K08 CA237726-01A1.
